New Vice-chair Appointed to Commission on Human Medicines
News Jan 27, 2015
The CHM advises on matters relating to safety, quality and the efficacy of medicines as well as the collection of adverse drug reactions.
Dr Angela Thomas is a consultant paediatric haematologist at the Royal Hospital for Sick Children in Edinburgh, a fellow of the Royal College of Physicians in Edinburgh, a former President of the British Society for Haematology and has been on the CHM since 2005, where she chairs the Clinical Trials, Biologicals & Vaccines Expert Advisory Group.
She has also served as a member and chaired many scientific and medical committees in the UK and Europe.
Dr Angela Thomas said: “I am delighted to be taking up this new role. The Commission plays a vital role in the licensing of new medicines and in monitoring drug safety. I have found my time as a member of CHM tremendously rewarding and am looking forward to the challenges offered in my new role as vice-chair.”
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE